CST 6.41% 8.3¢ castile resources ltd

I am not sure if this is helpfulIn settings with low background...

  1. 20,544 Posts.
    lightbulb Created with Sketch. 79
    I am not sure if this is helpful




    In settings with low background prevalence of tuberculosis (TB) infection, interferon-gamma release assays (IGRA) could be useful for diagnosing active TB. This study aims to evaluate the performance of QuantiFERON(R)-TB Gold (QFT-G) in the investigation for suspected active TB, with particular attention to patients originating in high-incidence countries.

    Furthermore, factors associated with QFT-G results in patients with active TB were assessed.

    Methods: From patients investigated for clinically suspected active TB, blood was obtained for QFT-G testing, in addition to routine investigations. Positive (PPV) and negative (NPV) predictive values for QFT-G were calculated, comparing patients with confirmed TB and those with other final diagnoses.

    QFT-G results in TB patients originating from countries with intermediate or high TB incidence were compared with QFT-G results from a control group of recently arrived asymptomatic immigrants from high-incidence countries. Factors associated with QFT-G outcome in patients with confirmed TB were assessed.

    Results: Among 141 patients, 41/70 (58.6%) with confirmed TB had a positive QFT-G test, compared to 16/71 (22.6%) patients with other final diagnoses, resulting in overall PPV of 71.9% and NPV of 67.6%.

    For patients with pulmonary disease, PPV and NPV were 61.1% and 67.7%, respectively, and 90.5% and 66.7% for subjects with extrapulmonary manifestations. Comparing patients from high-incidence countries with controls yielded a PPV for active TB of 76.7%, and a NPV of 82.7%.

    Patients with confirmed TB and positive QFT-G results were characterized by a lower median peripheral white blood cell count (5.9E9/L vs. 8.8E9/L; P<.001) and a higher median body mass index (22.7 vs.

    20.7; P=0.043) as compared to QFT-G-negative TB patients.

    Conclusions: The overall PPV and NPV of QFT-G for identifying active TB were unsatisfactory, especially for pulmonary disease. Thus, the usefulness of QFT-G for this purpose is questionable.

    However, a high PPV was observed for extrapulmonary TB and QFT-G might be considered in the diagnostic process in this situation. The PPV and NPV for identifying active TB among persons originating from regions with high-and intermediate TB incidence was similar to that observed in subjects originating in the low-incidence region.

    Author: Niclas WinqvistPer BjorkmanAnn NorenHakan Miorner
    Credits/Source: BMC Infectious Diseases 2009, 9:105



 
watchlist Created with Sketch. Add CST (ASX) to my watchlist
(20min delay)
Last
8.3¢
Change
0.005(6.41%)
Mkt cap ! $17.90M
Open High Low Value Volume
7.8¢ 8.3¢ 7.8¢ $12.47K 158.1K

Buyers (Bids)

No. Vol. Price($)
1 19230 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 31578 1
Last trade - 15.37pm 22/11/2024 (20 minute delay) ?
CST (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.